drugset / Trial / NCT00141219
Pregabalin Peripheral Neuropathic Pain Study
RandomizedParallel-groupQuadruple-blindTreatment
Summary
To evaluate the efficacy of pregabalin, using a flexible, optimized dose schedule with dose adjustment based on Daily Pain Rating Scale (DPRS), compared to placebo in subjects with peripheral neuropathic pain.
Timeline
- Start
- 2005-12
- Primary completion
- 2007-12
- Completion
- 2007-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Pregabalin | Small molecule | 150 mg | — |
| Subject | Pregabalin | Small molecule | 600 mg | — |